Model
Edge
Revance Therapeutics Inc.
0001848717
Filing Type
4
Filing Date
6/19/2023
Updated
6/20/23, 10:25 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership